CannLabs CANL Stock
CannLabs Price Chart
CannLabs CANL Financial and Trading Overview
CannLabs stock price | 0.0001 USD |
Previous Close | 0.00865 USD |
Open | 0.0089 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.0084 - 0.01 USD |
52 Week Range | 0.005 - 0.02 USD |
Volume | 11.4K USD |
Avg. Volume | 9.68K USD |
Market Cap | 11.56M USD |
Beta (5Y Monthly) | 1.550704 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
CANL Valuation Measures
Enterprise Value | 56.58K USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 6.7070312 |
Price/Book (mrq) | 1.05 |
Enterprise Value/Revenue | 0.033 |
Enterprise Value/EBITDA | -0.014 |
Trading Information
CannLabs Stock Price History
Beta (5Y Monthly) | 1.550704 |
52-Week Change | -38.46% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.02 USD |
52 Week Low | 0.005 USD |
50-Day Moving Average | 0.00818 USD |
200-Day Moving Average | 0.00995 USD |
CANL Share Statistics
Avg. Volume (3 month) | 9.68K USD |
Avg. Daily Volume (10-Days) | 2.94K USD |
Shares Outstanding | 62.63M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | N/A |
% Held by Institutions | N/A |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2014 |
Most Recent Quarter (mrq) | March 31, 2015 |
Next Fiscal Year End | December 31, 2015 |
Profitability
Profit Margin | -96.17% |
Operating Margin (ttm) | -250.14% |
Gross Margin | 32.04% |
EBITDA Margin | -231.64% |
Management Effectiveness
Return on Assets (ttm) | -362.15% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 1.72M USD |
Revenue Per Share (ttm) | 0.03 USD |
Quarterly Revenue Growth (yoy) | 319.09% |
Gross Profit (ttm) | 478.11K USD |
EBITDA | -3991213 USD |
Net Income Avi to Common (ttm) | -1689403 USD |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 17.59K USD |
Total Cash Per Share (mrq) | 0 USD |
Total Debt (mrq) | 2.4M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.086 |
Book Value Per Share (mrq) | 0.008 |
Cash Flow Statement
Operating Cash Flow (ttm) | -1702337 USD |
Levered Free Cash Flow (ttm) | -306306 USD |
Profile of CannLabs
Country | United States |
State | CO |
City | Denver |
Address | 3888 East Mexico Avenue |
ZIP | 80210 |
Phone | 303-309-0105 |
Website | N/A |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 37 |
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. is based in Denver, Colorado.
Q&A For CannLabs Stock
What is a current CANL stock price?
CannLabs CANL stock price today per share is 0.0001 USD.
How to purchase CannLabs stock?
You can buy CANL shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CannLabs?
The stock symbol or ticker of CannLabs is CANL.
Which industry does the CannLabs company belong to?
The CannLabs industry is Drug Manufacturers-Specialty & Generic.
How many shares does CannLabs have in circulation?
The max supply of CannLabs shares is 5.09B.
What is CannLabs Price to Earnings Ratio (PE Ratio)?
CannLabs PE Ratio is now.
What was CannLabs earnings per share over the trailing 12 months (TTM)?
CannLabs EPS is 0 USD over the trailing 12 months.
Which sector does the CannLabs company belong to?
The CannLabs sector is Healthcare.